BIORESTORATIVE THERAPIES, INC. Proceeds from Derivative Instrument, Investing Activities
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Proceeds from Derivative Instrument, Investing Activities of $2.48 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities · last filed 2022-03-30
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for the quarter ending 2020-03-31 was $2.48M, a 16.45% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for fiscal 2020 was $2.48M, a 62.66% decline from fiscal 2019.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for fiscal 2019 was $6.65M, a 71.62% increase from fiscal 2018.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for fiscal 2018 was $3.88M, a 1066.78% increase from fiscal 2017.
- BIORESTORATIVE THERAPIES, INC. proceeds from derivative instrument, investing activities for fiscal 2017 was $332.13K.
| Period end | Proceeds from Derivative Instrument, Investing Activities 3 month | Proceeds from Derivative Instrument, Investing Activities 6 month | Proceeds from Derivative Instrument, Investing Activities 9 month | Proceeds from Derivative Instrument, Investing Activities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $2.48M 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-12 | $0.00 derived: sum of 2 quarters · filed 2021-04-12 | $2.48M 10-Q · filed 2021-04-12 | $3.94M derived: sum of 4 quarters · filed 2021-04-30 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-12 | $2.48M 10-Q · filed 2021-04-12 | $3.94M derived: sum of 3 quarters · filed 2021-04-30 | $4.93M derived: sum of 4 quarters · filed 2021-04-30 |
| 2020-03-31 | $2.48M 10-Q · filed 2021-03-29 | $3.94M derived: sum of 2 quarters · filed 2021-04-30 | $4.93M derived: sum of 3 quarters · filed 2021-04-30 | $6.16M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-30 | $2.44M derived: sum of 2 quarters · filed 2021-04-30 | $3.68M derived: sum of 3 quarters · filed 2021-04-30 | $6.65M 10-K · filed 2021-04-30 |
| 2019-09-30 | $986.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $2.22M derived: sum of 2 quarters · filed 2019-11-13 | $5.20M 10-Q · filed 2019-11-13 | $6.76M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $4.21M 10-Q · filed 2019-08-14 | $5.77M derived: sum of 3 quarters · filed 2021-03-18 | $6.85M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $2.97M 10-Q · filed 2019-05-15 | $4.54M derived: sum of 2 quarters · filed 2021-03-18 | $5.61M derived: sum of 3 quarters · filed 2021-03-18 | $6.61M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.64M derived: sum of 2 quarters · filed 2021-03-18 | $3.64M derived: sum of 3 quarters · filed 2021-03-18 | $3.88M 10-K · filed 2021-03-18 |
| 2018-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $2.07M derived: sum of 2 quarters · filed 2018-11-13 | $2.31M 10-Q · filed 2018-11-13 | $2.54M derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-06-30 | $997.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.23M 10-Q · filed 2018-08-14 | $1.47M derived: sum of 3 quarters · filed 2019-03-29 | |
| 2018-03-31 | $235.61K 10-Q · filed 2018-05-15 | $467.44K derived: sum of 2 quarters · filed 2019-03-29 | ||
| 2017-12-31 | $231.82K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $332.13K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $100.31K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |